UnitedHealth Group's Q3 2015 earnings indicate strong performance in line with expectations.  Significant growth in revenues and earnings, coupled with positive guidance updates for 2016, along with management's optimistic outlook suggests a positive short-term impact on the stock price.  The focus on ongoing diversification and value-based care contracts further supports this positive trend.
[1]
